Planning for indefinite treatment from the beginning creates realistic expectations
379 GLP-1RAs, particularly PF1801, have demonstrated effective relief in inflammatory myopathies, such as polymyositis (PM), through preclinical studies
Stay sharp, stay current, and join us next time on Clinical Capsules.
One in five (19%) firms over 200 workers covers GLP-1 agonists for weight loss with more coverage among larger firms One-in-five (19%) firms with 200 or more workers, including 43% of firms with 5,000 or more workers, cover GLP-1 drugs for weight loss in their largest health plan in 2025
Troubleshooting the 60 mg vial Even with perfect technique, issues arise